Eli Lilly Current Ratio 2006-2018 | LLY

Current and historical current ratio for Eli Lilly (LLY) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Eli Lilly current ratio for the three months ending September 30, 2018 was 1.91.
Eli Lilly Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $20.69B $10.83B 1.91
2018-06-30 $18.33B $13.06B 1.40
2018-03-31 $16.26B $11.55B 1.41
2017-12-31 $19.20B $14.54B 1.32
2017-09-30 $17.43B $12.67B 1.38
2017-06-30 $15.75B $11.30B 1.39
2017-03-31 $12.98B $10.45B 1.24
2016-12-31 $15.10B $10.99B 1.38
2016-09-30 $13.39B $8.27B 1.62
2016-06-30 $12.98B $8.40B 1.55
2016-03-31 $11.72B $7.34B 1.60
2015-12-31 $12.57B $8.23B 1.53
2015-09-30 $12.57B $8.30B 1.51
2015-06-30 $12.35B $8.23B 1.50
2015-03-31 $11.74B $8.34B 1.41
2014-12-31 $11.93B $9.74B 1.23
2014-09-30 $12.11B $7.58B 1.60
2014-06-30 $13.16B $7.42B 1.77
2014-03-31 $13.04B $6.63B 1.97
2013-12-31 $13.11B $8.92B 1.47
2013-09-30 $13.20B $8.08B 1.64
2013-06-30 $12.64B $8.41B 1.50
2013-03-31 $12.33B $7.59B 1.62
2012-12-31 $13.04B $8.39B 1.55
2012-09-30 $14.04B $6.96B 2.02
2012-06-30 $12.31B $6.61B 1.86
2012-03-31 $12.60B $6.55B 1.92
2011-12-31 $14.25B $8.93B 1.60
2011-09-30 $14.57B $8.22B 1.77
2011-06-30 $14.95B $8.62B 1.73
2011-03-31 $15.35B $7.65B 2.01
2010-12-31 $14.84B $6.93B 2.14
2010-09-30 $14.18B $6.10B 2.33
2010-06-30 $12.47B $6.33B 1.97
2010-03-31 $12.25B $5.66B 2.17
2009-12-31 $12.49B $6.57B 1.90
2009-09-30 $11.81B $6.07B 1.95
2009-06-30 $10.94B $6.99B 1.57
2009-03-31 $10.26B $7.36B 1.40
2008-12-31 $12.45B $13.11B 0.95
2008-09-30 $12.95B $6.51B 1.99
2008-06-30 $12.68B $5.26B 2.41
2008-03-31 $12.49B $4.16B 3.00
2007-12-31 $12.32B $5.44B 2.27
2007-09-30 $10.45B $4.07B 2.57
2007-06-30 $9.56B $4.55B 2.10
2007-03-31 $9.25B $4.15B 2.23
2006-12-31 $9.69B $5.09B 1.91
2006-09-30 $9.77B $3.88B 2.52
2006-06-30 $10.59B $4.65B 2.28
2006-03-31 $10.36B $4.53B 2.29
2005-12-31 $10.80B $5.72B 1.89
2005-09-30 $11.95B $5.09B 2.35
2005-06-30 $10.95B $6.46B 1.70
2005-03-31 $11.26B $5.38B 2.09
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $120.583B $22.871B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.677B 18.36
Pfizer (PFE) United States $259.009B 14.60
Merck (MRK) United States $205.072B 17.77
Novartis AG (NVS) Switzerland $203.357B 17.38
AbbVie (ABBV) United States $137.681B 12.22
Sanofi (SNY) France $113.115B 14.01
Novo Nordisk (NVO) Denmark $107.931B 17.53
AstraZeneca (AZN) United Kingdom $103.013B 12.79
GlaxoSmithKline (GSK) United Kingdom $100.041B 13.45
Bristol-Myers Squibb (BMY) United States $88.253B 14.53